Despite largely favorable overall fourth-quarter 2012 results, Stryker Corp. emphasized the need to enlarge its foothold on overseas territory during its Jan. 23 earnings call.
Stryker Emphasizes Overseas Opportunities, Difficulties
Stryker reported generally positive earnings and revenue for 2012 despite struggles in Europe. The company is reorganizing its European business while developing its strategy for emerging markets.
More from Archive
More from Medtech Insight
• By
The intricate assembly of medical devices, often involving over 1,000 globally sourced components, faces severe disruption due to new US tariffs. These barriers could halt production and devastate small and medium-sized enterprises (SMEs), MedTech Europe’s CEO, Oliver Bisazza, warns in an interview with Medtech Insight.
• By
At AAOS, orthopedics players showcased their latest robotic-assisted platforms, power tools, 3D printed technologies and software offerings. This article brings you highlights from interviews Medtech Insight conducted on site with representatives from J&J, Stryker, Materialise and Canary Medical.
• By
A New South Korean law, the Digital Medical Products Act, enhances regulation for digital health products. Medical devices in the country are categorized both by risk and by similarity to already authorized devices. The approval process may stretch to 515 days for new manufacturers.